Key Highlights:

• Overall Growth: Worldwide sales increased by 5.3% in 4Q24 and 4.3% for the full year. However, when excluding currency impacts, operational growth reached 6.7% for 4Q24 and 5.9% for the full year, showing the strength of underlying business performance.
• "Worldwide 22,520$ 21,395 5.3 % 6.7 (1.4) 88,821$ 85,159 4.3 % 5.9 (1.6)"
• U.S. Strength: The U.S. market demonstrated robust growth, with a 10.0% sales increase in both 4Q24 and the full year.
• "U.S. 13,204$ 12,009 10.0 % 10.0 - 50,302$ 46,444 8.3 % 8.3 -"
• International Headwinds: International sales were negatively impacted by currency fluctuations and saw lower operational growth. Sales declined slightly by 0.7% in 4Q24, but with currency impacts removed, operational growth was 2.5%. For the full year, international sales decreased by 0.5%, with 2.9% operational growth.
• "International 9,316 9,386 (0.7) 2.5 (3.2) 38,519 38,715 (0.5) 2.9 (3.4)"
• COVID-19 Vaccine Impact: Sales from the COVID-19 vaccine are now negligible and have a limited impact on the current reporting. The analysis focuses on performance excluding these sales to reflect core business strength.
• "Worldwide excluding COVID-19 Vaccine (1) 22,520$ 21,351 5.5 % 6.9 (1.4) 88,623$ 84,042 5.5 % 7.0 (1.5)"

Key Highlights:

• Orders: Total orders surged by 46% to $15.5 billion.
• Revenue: GAAP revenue was $10.8 billion, a 14% increase, while adjusted revenue grew by 16% to $9.9 billion.
• Profitability: GAAP profit was $2.3 billion, up 37%, and operating profit saw an impressive 49% jump to $2.0 billion.
• EPS: Continuing GAAP EPS increased by 62% to $1.75, and adjusted EPS more than doubled to $1.32, a 103% increase.
• Cash Flow: Cash from operating activities grew by 5% to $1.3 billion, and free cash flow was up by 21% to $1.5 billion.
• Quote: “GE Aerospace delivered a strong finish to 2024 given robust demand for our services and products with fourth quarter orders up 46%, EPS more than doubling, and free cash flow increasing over 20%.”

Key Highlights

• Net Sales: $21.9 billion, a 2% increase compared to the prior year.
• Organic Sales: 3% increase year-over-year, driven by a 2% increase in volume and a 1% favorable geographic mix. Pricing had a neutral impact on sales growth. "Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased three percent versus the prior year."
• Diluted EPS: $1.88, a significant 34% increase year-over-year, primarily due to a non-cash impairment of the Gillette intangible asset in the base year.
• Core EPS: $1.88, a 2% increase compared to the prior year. "Core earnings per share were $1.88, an increase of two percent versus prior year."
• Operating Cash Flow: $4.8 billion for the quarter.
• Net Earnings: $4.7 billion for the quarter.
• Adjusted Free Cash Flow Productivity: 84%.
• Cash Return to Shareholders: Over $4.9 billion returned to shareholders through $2.4 billion in dividend payments and $2.5 billion in share repurchases.